Patents by Inventor Franck Oury

Franck Oury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Osteocalcin as a treatment for cognitive disorders
    Publication number: 20190381142
    Abstract: Methods and compositions for treating or preventing cognitive disorders in mammals, preferably humans, are provided. The methods generally involve modulation of the OST-PTP signaling pathway or the PTP-1B signaling pathway involving gamma-carboxylase and osteocalcin, e.g., by administratin of undercarboxylated/uncarboxylated osteocalcin. Disorders amenable to treatment by the methods include, but are not limited to, cognitive loss due to neurodegeneration associated with aging, anxiety, depression, memory loss, learning difficulties, and cognitive disorders associated with food deprivation during pregnancy.
    Type: Application
    Filed: August 20, 2018
    Publication date: December 19, 2019
    Inventors: Gerard Karsenity, Franck Oury
  • Osteocalcin as a treatment for cognitive disorders
    Patent number: 10052364
    Abstract: Methods and compositions for treating or preventing cognitive disorders in mammals, preferably humans, are provided. The methods generally involve modulation of the OST-PTP signaling pathway or the PTP-1B signaling pathway involving gamma-carboxylase and osteocalcin, e.g., by administration of undercarboxylated/uncarboxylated osteocalcin. Disorders amenable to treatment by the methods include, but are not limited to, cognitive loss due to neurodegeneration associated with aging, anxiety, depression, memory loss, learning difficulties, and cognitive disorders associated with food deprivation during pregnancy.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 21, 2018
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Gerard Karsenty, Franck Oury
  • Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2
    Publication number: 20120115778
    Abstract: Methods for treating eating disorders associated with excessive weight gain, suppressing appetite, reducing body weight, or treating obesity in an animal by administering one or more antagonists of the serotonin Htr1a or Htr2b receptor, or a Tph2 inhibitor are provided, or combinations thereof.
    Type: Application
    Filed: July 15, 2010
    Publication date: May 10, 2012
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Gerard Karsenty, Vijay Yadav, Franck Oury